Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nickolas Papadopoulos

Showing results (81-90 of 183) with videos related to

Pageof 19
Sort By:
The Journal of Clinical Investigation|May 1, 2020
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonistsMaximilian F Konig, Mike Powell, Verena Staedtke, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 10, 2024
Outcomes Following a False-Positive Multi-Cancer Early Detection Test: Results from DETECT-A, the First Large, Prospective, Interventional MCED StudyAnne M Lennon, Adam H Buchanan, Seema P Rego, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2026
Lethal toxin-equipped effector cells for the potential treatment of cancerAlexander H Pearlman, Brian J Mog, Michael S Hwang, et al.
Oncotarget|April 8, 2017
Genetic landscape of extreme responders with anaplastic oligodendrogliomaMatthias Holdhoff, Gregory J Cairncross, Thomas M Kollmeyer, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Engineering immunotoxin-equipped effector cells and evaluation in primary human immune cellsAlexander H Pearlman, Brian J Mog, Michael S Hwang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 12, 2016
High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladderMorgan Cowan, Simeon Springer, Doreen Nguyen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 5, 2024
Outcomes following a false positive multi-cancer early detection (MCED) test: Results from DETECT-A, the first large, prospective, interventional MCED studyAnne Marie Lennon, Adam H Buchanan, Seema P Rego, et al.
Gastroenterology|January 25, 2021
Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients With Barrett's EsophagusChristopher Douville, Helen R Moinova, Prashanthi N Thota, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2019
Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinomaMarie-Lisa Eich, Maria Del Carmen Rodriguez Pena, Simeon U Springer, et al.
Science Translational Medicine|August 9, 2013
Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencingMargaret L Hoang, Chung-Hsin Chen, Viktoriya S Sidorenko, et al.
Pageof 19

Showing results (81-90 of 183) with videos related to

Sort By:
Pageof 19
The Journal of Clinical Investigation|May 1, 2020
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonistsMaximilian F Konig, Mike Powell, Verena Staedtke, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 10, 2024
Outcomes Following a False-Positive Multi-Cancer Early Detection Test: Results from DETECT-A, the First Large, Prospective, Interventional MCED StudyAnne M Lennon, Adam H Buchanan, Seema P Rego, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2026
Lethal toxin-equipped effector cells for the potential treatment of cancerAlexander H Pearlman, Brian J Mog, Michael S Hwang, et al.
Oncotarget|April 8, 2017
Genetic landscape of extreme responders with anaplastic oligodendrogliomaMatthias Holdhoff, Gregory J Cairncross, Thomas M Kollmeyer, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Engineering immunotoxin-equipped effector cells and evaluation in primary human immune cellsAlexander H Pearlman, Brian J Mog, Michael S Hwang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 12, 2016
High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladderMorgan Cowan, Simeon Springer, Doreen Nguyen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 5, 2024
Outcomes following a false positive multi-cancer early detection (MCED) test: Results from DETECT-A, the first large, prospective, interventional MCED studyAnne Marie Lennon, Adam H Buchanan, Seema P Rego, et al.
Gastroenterology|January 25, 2021
Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients With Barrett's EsophagusChristopher Douville, Helen R Moinova, Prashanthi N Thota, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2019
Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinomaMarie-Lisa Eich, Maria Del Carmen Rodriguez Pena, Simeon U Springer, et al.
Science Translational Medicine|August 9, 2013
Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencingMargaret L Hoang, Chung-Hsin Chen, Viktoriya S Sidorenko, et al.
Pageof 19